CareLit Fachartikel

Valsartan fetopathy: a case report

B Huber, C Schindera, B Utsch, M Nelle, R Gerull · Zeitschrift für Geburtshilfe und Neonatologie · 2009 · Heft 04

Dokument
1042777
CareLit-ID
Jahr
2009
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Zeitschrift für Geburtshilfe und Neonatologie
Autor:innen
B Huber, C Schindera, B Utsch, M Nelle, R Gerull
Ausgabe
Heft 04 / 2009
Seiten
–
Erschienen: 2009-04-24 00:00:00
ISSN
0948-2393
DOI
10.1055/s-0029-1223055

Zusammenfassung

Aims: ACE inhibitors and angiotensin II receptor type 1 antagonists (sartans) are contraindicated during pregnancy due to impaired renal development resulting in tubular dysgenesis. The wide spectrum of manifestations ranges from death as a result of severe complications of renal failure to reversible effects on amniotic fluid after drug withdrawl as well as late preterm and term gestations with only minor problems during neonatal period and favorable outcome concerning renal function. Case report: At 35 weeks of gestation a 34-year old woman who received valsartan during whole pregnancy for essential hypertensi…

Schlagworte

angiotensin II receptor antagonists anhydramnion fetopathy renal failure valsartan Angiotensin II Angiotensin Amniotic Fluid Creatinine Dialysis Anuria After Zeitschrift für Geburtshilfe und Neonatologie